Items where contributor is "Nüesch, Reto"

2011

Wildi, K. and Tschudin-Sutter, S. and Dell-Kuster, S. and Frei, R. and Bucher, H. C. and Nüesch, R.. (2011) Factors associated with positive blood cultures in outpatients with suspected bacteremia. European journal of clinical microbiology & infectious diseases, Vol. 30, H. 12. pp. 1615-1619.

Nüesch, R.. (2011) [Focal points in tuberculosis research yesterday and today]. Schweizerische Rundschau für Medizin PRAXIS, Vol. 100. pp. 523-524.

Hunziker, Sabina and Schläpfer, Martin and Langewitz, Wolf and Kaufmann, Gilbert and Nüesch, Reto and Battegay, Edouard and Zimmerli, Lukas U.. (2011) Open and hidden agendas of "asymptomatic" patients who request check-up exams. BMC family practice, Vol. 12. pp. 1-7.

2010

Fritz, Stefanie and Mossdorf, Erik and Durovic, Bojana and Zenhaeusern, Gabriela and Conen, Anna and Steffen, Ingrid and Battegay, Manuel and Nüesch, Reto and Hess, Christoph. (2010) Virosomal influenza-vaccine induced immunity in HIV-infected individuals with high versus low CD4+ T-cell counts : clues towards a rational vaccination strategy. AIDS, Vol. 24, H. 14. pp. 2287-2289.

Nüesch, R.. (2010) ESBL, MRSA, chinolonresistente E.coli, Clostridium difficile B1, NAP1/027. Praxis : Schweizerische Rundschau für Medizin, Vol. 99, Nr. 13. p. 751.

2009

Wolff, Thomas and Leupold, Judith and Nüesch, Reto. (2009) Bang! The smoker with suprapubic pain. Lancet : a journal of British and foreign medicine, surgery, obstetrics, physiology, chemistry, pharmacology, public health and news, Vol. 374. p. 174.

Mocroft, A. and Wyatt, C. and Szczech, L. and Neuhaus, J. and El-Sadr, W. and Tracy, R. and Kuller, L. and Shlipak, M. and Angus, B. and Klinker, H. and Ross, M. and Insight, Smart Study Group. (2009) Interruption of antiretroviral therapy is associated with increased plasma cystatin C. AIDS : official journal of the International AIDS Society, Vol. 23. pp. 71-82.

Nüesch, Reto and Gayet-Ageron, Angèle and Chetchotisakd, Ploenchan and Prasithsirikul, Wisit and Kiertiburanakul, Sasisopin and Munsakul, Warangkana and Raksakulkarn, Phitsanu and Tansuphasawasdikul, Somboon and Chautrakarn, Sineenart and Ruxrungtham, Kiat and Hirschel, Bernard and Anaworanich, Jintanat. (2009) The impact of combination antiretroviral therapy and its interruption on anxiety, stress, depression and quality of life in Thai patients. The open AIDS journal, Vol. 3. pp. 38-45.

2008

Thierfelder, C. and Schill, C. and Hatz, C. and Nüesch, R.. (2008) Trends in imported malaria to Basel, Switzerland. Journal of travel medicine, Vol. 15. pp. 432-436.

Ananworanich, J. and Gayet-Ageron, A. and Ruxrungtham, K. and Chetchotisakd, P. and Prasithsirikul, W. and Kiertiburanakul, S. and Munsakul, W. and Raksakulkarn, P. and Tansuphasawadikul, S. and LeBraz, M. and Jupimai, T. and Ubolyam, S. and Schutz, M. and Hirschel, B. and Staccato, Thailand Study Group. (2008) Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir. Antiviral therapy, Vol. 13. pp. 375-380.

Nüesch, R. and Ananworanich, J. and Srasuebkul, P. and Chetchotisakd, P. and Prasithsirikul, W. and Klinbuayam, W. and Mahanontharit, A. and Jupimai, T. and Ruxrungtham, K. and Hirschel, B.. (2008) Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection. AIDS, Vol. 22. pp. 152-154.

Fox, Z. and Phillips, A. and Cohen, C. and Neuhaus, J. and Baxter, J. and Emery, S. and Hirschel, B. and Hullsiek, K. H. and Stephan, C. and Lundgren, J. and Smart, Study Group. (2008) Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. AIDS, Vol. 22. pp. 2279-2289.

Strategies, for Management of Antiretroviral Therapy Study Group and Emery, S. and Neuhaus, J. A. and Phillips, A. N. and Babiker, A. and Cohen, C. J. and Gatell, J. M. and Girard, P. M. and Grund, B. and Law, M. and Losso, M. H. and Palfreeman, A. and Wood, R.. (2008) Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. Journal of infectious diseases, Vol. 197, no. 8. pp. 1133-1144.

Strategies, for Management of Antiretroviral Therapy Study Group and Lundgren, J. D. and Babiker, A. and El-Sadr, W. and Emery, S. and Grund, B. and Neaton, J. D. and Neuhaus, J. and Phillips, A. N.. (2008) Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study : role of CD4+ Cell counts and HIV RNA levels during follow-up. Journal of infectious diseases, Vol. 197, no. 8. pp. 1145-1155.

Ananworanich, J. and Nuesch, R. and Côté, H. C. and Kerr, S. J. and Hill, A. and Jupimai, T. and Laopraynak, N. and Saenawat, S. and Ruxrungtham, K. and Hirschel, B.. (2008) Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine : a Staccato trial substudy. Journal of Antimicrobial Chemotherapy, Vol. 61. pp. 1340-1343.

Smart, Study Group and El-Sadr, W. M. and Grund, B. and Neuhaus, J. and Babiker, A. and Cohen, C. J. and Darbyshire, J. and Emery, S. and Lundgren, J. D. and Phillips, A. and Neaton, J. D.. (2008) Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Annals of internal medicine, Vol. 149, H. 5. pp. 289-299.

Burri, E. and Nüesch, R. and Lugli, A. and Noll, P. and Vavricka, S. R.. (2008) [Early gastric cancer--or not]. Schweizerische Rundschau für Medizin PRAXIS, Vol. 97. pp. 1351-1355.

Erb, S. and Nüesch, R.. (2008) [Tuberculous lymphadenitis]. Schweizerische Rundschau für Medizin PRAXIS, Vol. 97. pp. 33-37.

Burri, E. and Nüesch, R. and Zulewski, H.. (2008) [Hyperprolactinemia in a man's world]. Schweizerische Rundschau für Medizin PRAXIS, Vol. 97, H. 24. pp. 1295-1299.

Nüesch, R.. (2008) [Antibiotics in the treatment of adults with clinically diagnosed acute rhinosinusitis]. Schweizerische Rundschau für Medizin PRAXIS, Vol. 97. pp. 651-652.